Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.

作者: Eugene W. Tryciecky , Alexander Gottschalk , Kelly Ludema

DOI: 10.1016/S0001-2998(97)80044-X

关键词:

摘要: There are many radionuclides currently used in oncologic imaging including technetium 99m diphosphonates, gallium 67, thallium 201, sestamibi, and others. The specific interactions of each these agents with computed tomography (CT) magnetic resonance (MRI) extensive. radionuclide bone scan using Tc diphosphonate is the most frequently performed nuclear medicine examination imaging. can be as a model to generalize CT MRI. applications for other procedures include evaluating metastases, assessing response therapy, guiding radiation therapy planning. Bone findings that equivolcal metastases evaluated modalities. Areas abnormal uptake axial skeleton or MRI, whereas those appendicular plain radiographs, followed by MRI if necessary. valuable because its high sensitivity lesion detection, ease whole body imaging, low cost. major disadvantage it lacks fine anatomic detail, which particular importance cancer patient local back pain, radiculopathy, myelopathy. Because pain without radiculopathy earliest symptom spinal cord compression 90% patients, an study choice exquisite depiction anatomy. A myelogram postmyelogram there contraindications basic principle detection provided detail applied also use

参考文章(36)
Prandini N, Spanedda R, Scapoli Gl, Gennari M, Feggi Lm, Orzincolo C, Scutellari Pn, Bagni B, Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology Radiologia Medica. ,vol. 76, pp. 311- 315 ,(1988)
M A Bender, M Blau, W Nagler, Fluorine-18: a new isotope for bone scanning. The Journal of Nuclear Medicine. ,vol. 3, pp. 332- 334 ,(1962)
G. Subramanian, J. G. McAfee, A new complex of 99mTc for skeletal imaging. Radiology. ,vol. 99, pp. 192- 196 ,(1971) , 10.1148/99.1.192
David M. Paushter, Frederich H. Dengel, Michael T. Modic, Paul M. Duchesneau, Meredith A. Weinstein, Clinical applications of nuclear magnetic resonance Radiographics. ,vol. 4, pp. 97- 112 ,(1984) , 10.1148/RADIOGRAPHICS.4.1.97
Thomas Wiebe, Helena Willen, Kristian Herrlin, Flare phenomenon in osteosarcoma after complete remission The Journal of Nuclear Medicine. ,vol. 36, pp. 1429- 1431 ,(1995)
WILLIAM D. JOHNS, MARC B. GARNICK, WILLIAM D. KAPLAN, Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan. Clinical Nuclear Medicine. ,vol. 15, pp. 485- 487 ,(1990) , 10.1097/00003072-199007000-00006
Joseph E. Oesterling, The Use of Prostate-Specific Antigen in Staging Patients With Newly Diagnosed Prostate Cancer JAMA: The Journal of the American Medical Association. ,vol. 269, pp. 57- 60 ,(1993) , 10.1001/JAMA.1993.03500010067033
Martin E. Gleave, David Coupland, Darrel Drachenberg, Leslie Cohen, Stephen Kwong, S. Larry Goldenberg, Lorne D. Sullivan, Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer Urology. ,vol. 47, pp. 708- 712 ,(1996) , 10.1016/S0090-4295(96)80016-1
SHIGERU KOSUDA, TAKEHIKO GOKAN, KOHE TAMURA, TAKUSHI DOKIYA, ATSUSHI KUBO, SHOZO HASHIMOTO, Radionuclide imaging of two patients with metastasis to a distal phalanx of the hand Clinical Nuclear Medicine. ,vol. 11, pp. 659- 660 ,(1986) , 10.1097/00003072-198609000-00016
L M. WHITE, B. G. GRAY, M. ICHISE, J. C. KIRSH, R. BURKES, Scintigraphic flare in skeletal lymphoma. Clinical Nuclear Medicine. ,vol. 19, pp. 661- 664 ,(1994) , 10.1097/00003072-199408000-00001